192 related articles for article (PubMed ID: 23233749)
1. Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.
Beard AJ; Hofer TP; Downs JR; Lucatorto M; Klamerus ML; Holleman R; Kerr EA;
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):66-74. PubMed ID: 23233749
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
[TBL] [Abstract][Full Text] [Related]
3. Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans.
Vimalananda VG; Miller DR; Hofer TP; Holleman RG; Klamerus ML; Kerr EA
J Gen Intern Med; 2013 Jul; 28 Suppl 2(Suppl 2):S529-35. PubMed ID: 23807061
[TBL] [Abstract][Full Text] [Related]
4. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
[TBL] [Abstract][Full Text] [Related]
5. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
[TBL] [Abstract][Full Text] [Related]
6. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
Marrett E; Zhao C; Zhang NJ; Zhang Q; Ramey DR; Tomassini JE; Tershakovec AM; Neff DR
Vasc Health Risk Manag; 2014; 10():237-46. PubMed ID: 24851051
[TBL] [Abstract][Full Text] [Related]
7. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
Le NA; Tomassini JE; Tershakovec AM; Neff DR; Wilson PW
J Am Heart Assoc; 2015 Oct; 4(10):e001675. PubMed ID: 26486166
[TBL] [Abstract][Full Text] [Related]
8. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II
Hermans MP; Gevaert S; Descamps O; Missault L; Gillot B; De Keyzer D; Lautsch D; Brudi P; Ambegaonkar B; Vyas A; Horack M; Gitt A
Acta Clin Belg; 2019 Dec; 74(6):399-404. PubMed ID: 30355016
[No Abstract] [Full Text] [Related]
9. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.
Sukhija R; Prayaga S; Marashdeh M; Bursac Z; Kakar P; Bansal D; Sachdeva R; Kesan SH; Mehta JL
J Investig Med; 2009 Mar; 57(3):495-9. PubMed ID: 19188844
[TBL] [Abstract][Full Text] [Related]
10. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
[TBL] [Abstract][Full Text] [Related]
11. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
Pokharel Y; Akeroyd JM; Ramsey DJ; Hira RS; Nambi V; Shah T; Woodard LD; Winchester DE; Ballantyne CM; Petersen LA; Virani SS
Clin Cardiol; 2016 Apr; 39(4):185-91. PubMed ID: 27059708
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
Blom DJ; Ranjith N; Joshi P; Naidoo P; van Tonder A; Musa MG; Joshi S; Leisegang R; Trokis JS; Makan H; Raal FJ
Cardiovasc J Afr; 2020; 31(5):245-251. PubMed ID: 33151240
[TBL] [Abstract][Full Text] [Related]
13. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
Jones PH; Nair R; Thakker KM
J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
17. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
[TBL] [Abstract][Full Text] [Related]
18. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients ≥65 years (from the Lipid Treatment Assessment Project [L-TAP] 2).
Rodriguez F; Santos RD; Messig M; Tarasenko L; Ferrières J; Jukema JW; Chiang CW; Waters DD; Foody JM;
Am J Cardiol; 2012 Jun; 109(12):1738-42. PubMed ID: 22440124
[TBL] [Abstract][Full Text] [Related]
20. Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.
Simpson RJ; Tunceli K; Ramey DR; Neff DR; Kern DM; Hsieh HM; Wertz DA; Stephenson JJ; Marrett E; Tomassini JE; Jacobson TA
J Clin Lipidol; 2013; 7(5):399-407. PubMed ID: 24079280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]